Balance Sheet

Accounts Payables Accumulated Depreciation Accumulated Expenses Assets Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Dividends payables Finished Goods Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Accured Receivables - Affiliates Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Abvc Biopharma (ABVC) Current Taxes (2023 - 2025)

Abvc Biopharma (ABVC) has disclosed Current Taxes for 3 consecutive years, with $11964.0 as the latest value for Q4 2025.

For the quarter ending Q4 2025, Current Taxes changed N/A year-over-year to $11964.0, compared with a TTM value of $11964.0 through Dec 2025, changed N/A, and an annual FY2025 reading of $11964.0, changed N/A over the prior year.
Current Taxes was $11964.0 for Q4 2025 at Abvc Biopharma, up from $6170.0 in the prior quarter.
Across five years, Current Taxes topped out at $112946.0 in Q4 2023 and bottomed at $6170.0 in Q3 2025.
Average Current Taxes over 3 years is $52542.2, with a median of $23521.0 recorded in 2025.